Compare PSIX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSIX | VCEL |
|---|---|---|
| Founded | 1985 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | 1997 |
| Metric | PSIX | VCEL |
|---|---|---|
| Price | $63.03 | $36.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $98.76 | $60.40 |
| AVG Volume (30 Days) | 506.2K | ★ 579.0K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 122.27 | ★ 236.54 |
| EPS | ★ 5.26 | 0.25 |
| Revenue | ★ $675,481,000.00 | $258,716,999.00 |
| Revenue This Year | $48.27 | $17.86 |
| Revenue Next Year | $14.25 | $18.55 |
| P/E Ratio | ★ $11.97 | $148.17 |
| Revenue Growth | ★ 54.78 | 14.05 |
| 52 Week Low | $15.30 | $29.24 |
| 52 Week High | $121.78 | $63.00 |
| Indicator | PSIX | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 45.31 |
| Support Level | $60.49 | $35.85 |
| Resistance Level | $62.26 | $42.68 |
| Average True Range (ATR) | 3.82 | 1.63 |
| MACD | 2.21 | -0.32 |
| Stochastic Oscillator | 76.69 | 12.60 |
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.